Dominguez-Medina, C.C.; Rash, N.L.; Robillard, S.; Robinson, C.; Efstratiou, A.; Broughton, K.; Parkhill, J.; Holden, M.T.G.; Lopez-Alvarez, M.R.; Paillot, R.;
et al. SpeS: A Novel Superantigen and Its Potential as a Vaccine Adjuvant against Strangles. Int. J. Mol. Sci. 2020, 21, 4467.
https://doi.org/10.3390/ijms21124467
AMA Style
Dominguez-Medina CC, Rash NL, Robillard S, Robinson C, Efstratiou A, Broughton K, Parkhill J, Holden MTG, Lopez-Alvarez MR, Paillot R,
et al. SpeS: A Novel Superantigen and Its Potential as a Vaccine Adjuvant against Strangles. International Journal of Molecular Sciences. 2020; 21(12):4467.
https://doi.org/10.3390/ijms21124467
Chicago/Turabian Style
Dominguez-Medina, C. Coral, Nicola L. Rash, Sylvain Robillard, Carl Robinson, Androulla Efstratiou, Karen Broughton, Julian Parkhill, Matthew T.G. Holden, Maria R. Lopez-Alvarez, Romain Paillot,
and et al. 2020. "SpeS: A Novel Superantigen and Its Potential as a Vaccine Adjuvant against Strangles" International Journal of Molecular Sciences 21, no. 12: 4467.
https://doi.org/10.3390/ijms21124467
APA Style
Dominguez-Medina, C. C., Rash, N. L., Robillard, S., Robinson, C., Efstratiou, A., Broughton, K., Parkhill, J., Holden, M. T. G., Lopez-Alvarez, M. R., Paillot, R., & Waller, A. S.
(2020). SpeS: A Novel Superantigen and Its Potential as a Vaccine Adjuvant against Strangles. International Journal of Molecular Sciences, 21(12), 4467.
https://doi.org/10.3390/ijms21124467